美国血液技术(HAE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HAE 美国血液技术

盘后交易 05-07 16:51:42 EDT

95.20

-0.18

-0.19%

盘后95.51

+0.31+0.32%

16:10 EDT

最高97.13	最低94.94	成交量72.81万
今开95.47	昨收95.38	日振幅2.29%
总市值48.35亿	流通市值47.96亿	总股本5,079万
成交额6,955万	换手率1.45%	流通股本5,037万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"HAE","market":"US","secType":"STK","nameCN":"美国血液技术","latestPrice":95.2,"timestamp":1715112000000,"preClose":95.38,"halted":0,"volume":728124,"hourTrading":{"tag":"盘后","latestPrice":95.509,"preClose":95.2,"latestTime":"16:10 EDT","volume":22968,"amount":2186650.98432,"timestamp":1715112608979},"delay":0,"floatShares":50374419,"shares":50786117,"eps":2.460205,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.18,"latestTime":"05-07 16:51:42 EDT","open":95.47,"high":97.125,"low":94.94,"amount":69550804.9482,"amplitude":0.022908,"askPrice":101,"askSize":10,"bidPrice":93.36,"bidSize":18,"shortable":3,"etf":0,"ttmEps":2.460205,"exchange":"NYSE","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1715126400000},"adr":0,"listingDate":673761600000,"adjPreClose":95.38,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":95.509,"preClose":95.2,"latestTime":"16:10 EDT","volume":22968,"amount":2186650.98432,"timestamp":1715112608979},"volumeRatio":1.792562},"requestUrl":"/m/hq/s/HAE/","defaultTab":"news","newsList":[{"id":"2433722778","title":"Haemonetics Corp   预计每股收益89美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433722778","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433722778?lang=zh_cn&edition=full","pubTime":"2024-05-07 18:03","pubTimestamp":1715076181,"startTime":"0","endTime":"0","summary":"   * Haemonetics Corp    将于5月9日公布截至2024年3月31日的财报，预计季度收入将有所增长。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于波士顿马萨诸塞州的公司的营收将从去年同期的3.0442亿美元增至3.29113亿美元，增幅为8.1%。* LSEG 分析师对 Haemonetics 公司的平均预期为每股收益 89 美分。* 华尔街对 Haemonetics Corp 的 12 个月目标价中值为 105.00 美元，高于其上一交易日 95.38 美元的收盘价。5月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426739480","title":"Barrington Research：维持Haemonetics(HAE.US)评级，由优于大市调整至优于大市评级, 目标价由105.00美元调整至105.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426739480","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426739480?lang=zh_cn&edition=full","pubTime":"2024-04-12 22:55","pubTimestamp":1712933721,"startTime":"0","endTime":"0","summary":"Barrington Research：维持Haemonetics(HAE.US)评级，由优于大市调整至优于大市评级, 目标价由105.00美元调整至105.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412225526876fb12b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412225526876fb12b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417744763","title":"BUZZ-Haemonetics 因收购医疗设备制造商 Attune Medical 的交易而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2417744763","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417744763?lang=zh_cn&edition=full","pubTime":"2024-03-06 01:50","pubTimestamp":1709661044,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月5日 - ** 医疗保健公司Haemonetics  股价上涨1.8%至76.13美元 ** 该公司宣布 (link) 收购私营医疗设备制造商 Attune Medical 的最终协议 ** 作为交易的一部分，HAE将获得Attune的食道冷却设备ensoETM，该设备有助于减少手术过程中的食道损伤。** 根据交易，Co 将向 Attune 支付 1.6 亿美元的预付现金和未来的里程碑付款 ** 预计交易将于 2025 财年第一季度完成 - HAE** 包括盘中走势在内，该股在过去12个月下跌了1.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2415259968","title":"百度健康上线罕见病中心，法布雷病及HAE患者可开展线上自筛","url":"https://stock-news.laohu8.com/highlight/detail?id=2415259968","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2415259968?lang=zh_cn&edition=full","pubTime":"2024-02-29 16:11","pubTimestamp":1709194260,"startTime":"0","endTime":"0","summary":"由健康管理平台百度健康携手中国罕见病联盟共建的\"罕见病中心\"正式升级上线。在我国，法布雷病的总体筛查诊断率仅为3%。延迟诊断会增加HAE患者因喉部水肿发作导致的死亡风险。此次百度健康上线\"罕见病中心\"将为这些疾病提供科普和自筛指引，一方面提升大众对于法布雷病及HAE的疾病认知，另一方面帮助公众在面对疾病威胁时能够做到\"早筛查、早发现，早治疗\"，从而提高诊断意识。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4349121_ZH49121_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411355969","title":"更新版 1-KalVista 在遗传病后期试验中达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2411355969","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411355969?lang=zh_cn&edition=full","pubTime":"2024-02-13 20:10","pubTimestamp":1707826232,"startTime":"0","endTime":"0","summary":"     路透社2月13日 - KalVista Pharmaceuticals   周二称，其治疗一种遗传性疾病的疗法在一项后期试验中达到了主要目标，这种疾病会导致皮下和身体其他部位迅速肿胀。这种名为sebetralstat的疗法显示，遗传性血管性水肿 患者开始缓解症状的速度明显快于安慰剂。使用低剂量的sebetralstat，症状开始缓解的中位时间为1.61小时，而使用安慰剂则为6.72小时。Sebetralstat在136名成人和青少年HAE患者中进行了测试，HAE是一种因缺乏某种名为C1-抑制因子的蛋白质或其功能障碍而引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409571740","title":"美国血液技术盘中异动 快速拉升5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409571740","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409571740?lang=zh_cn&edition=full","pubTime":"2024-02-08 22:34","pubTimestamp":1707402865,"startTime":"0","endTime":"0","summary":"北京时间2024年02月08日22时34分，美国血液技术股票出现波动，股价大幅上涨5.39%。截至发稿，该股报81.27美元/股，成交量1245股，换手率0.00%，振幅0.09%。美国血液技术股票所在的医疗设备行业中，整体跌幅为0.36%。其相关个股中，中进医疗、Femasys Inc、美国血液技术涨幅较大，Nanostring Technologies Inc、Femasys Inc、中进医疗较为活跃，换手率分别为6.39%、0.74%、0.31%，振幅较大的相关个股有中进医疗、Nanostring Technologies Inc、Femasys Inc，振幅分别为19.35%、12.97%、8.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208223425877e0b09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208223425877e0b09&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409718264","title":"Haemonetics Corp   预计每股收益94美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2409718264","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409718264?lang=zh_cn&edition=full","pubTime":"2024-02-06 19:38","pubTimestamp":1707219537,"startTime":"0","endTime":"0","summary":"   * Haemonetics Corp    将于2月8日公布截至2023年12月31日的财报，预计季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于波士顿马萨诸塞州的公司的营收将从去年同期的3.053亿美元增至3.2029亿美元，增幅为4.9%。* LSEG 分析师对 Haemonetics 公司的平均预期为每股收益 94 美分。* 华尔街对 Haemonetics Corp 的 12 个月目标价中位数为 105.00 美元，高于上一交易日的收盘价 75.38 美元。2月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2384369164","title":"美国血液技术盘中异动 大幅下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2384369164","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2384369164?lang=zh_cn&edition=full","pubTime":"2023-11-18 01:02","pubTimestamp":1700240554,"startTime":"0","endTime":"0","summary":"北京时间2023年11月18日01时02分，美国血液技术股票出现异动，股价快速跳水5.02%。截至发稿，该股报84.74美元/股，成交量18.469万股，换手率0.36%，振幅4.93%。美国血液技术股票所在的医疗设备行业中，整体涨幅为0.08%。美国血液技术公司简介：美国血液技术公司旨在通过在血液和血浆成分采集、外科病房和医院输血服务空间提供医疗产品和解决方案，改善患者护理，降低医疗保健成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231118010234839d8e4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231118010234839d8e4f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2382321747","title":"美国血液技术2023财年第三财季实现净利润24.91百万美元，同比减少24.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2382321747","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2382321747?lang=zh_cn&edition=full","pubTime":"2023-11-11 00:20","pubTimestamp":1699633240,"startTime":"0","endTime":"0","summary":"9月30日，美国血液技术公布财报，公告显示公司2023财年第三财季净利润为24.91百万美元，同比减少24.97%；其中营业收入为3.18亿美元，同比增加7.07%，每股基本收益为0.49美元。从资产负债表来看，美国血液技术总负债11.18亿美元，其中短期债务13.57百万美元，资产负债比为1.80，流动比率为3.29。机构评级：截至2023年9月30日，当前有6家机构对美国血液技术目标价做出预测，其中目标均价为107.83美元，其中最低目标价为95.00美元，最高目标价为115.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231111002042840487da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231111002042840487da&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.haemonetics.com","stockEarnings":[{"period":"1week","weight":0.0424},{"period":"1month","weight":0.1268},{"period":"3month","weight":0.2371},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.1596},{"period":"ytd","weight":0.1154}],"compareEarnings":[{"period":"1week","weight":0.0128},{"period":"1month","weight":-0.0036},{"period":"3month","weight":0.0457},{"period":"6month","weight":0.1814},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Haemonetics Corporation成立于1971年，是一个全球性医疗设备公司,致力于为客户提供创新的血液管理解决方案——血浆来源收集者,采血机构和医院,在输血行业医疗设备系统方面有着强大的品牌优势,为客户提供解决方案的同时还提供信息技术平台和增值服务,其解决方案帮助患者改善临床结果，并提高血液中的供应链效率。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.01405},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.011877},{"month":3,"riseRate":0.69697,"avgChangeRate":0.022898},{"month":4,"riseRate":0.484848,"avgChangeRate":-0.025124},{"month":5,"riseRate":0.545455,"avgChangeRate":0.019655},{"month":6,"riseRate":0.606061,"avgChangeRate":0.020417},{"month":7,"riseRate":0.666667,"avgChangeRate":0.016689},{"month":8,"riseRate":0.757576,"avgChangeRate":0.035488},{"month":9,"riseRate":0.515152,"avgChangeRate":0.015262},{"month":10,"riseRate":0.515152,"avgChangeRate":-0.002825},{"month":11,"riseRate":0.515152,"avgChangeRate":0.023869},{"month":12,"riseRate":0.606061,"avgChangeRate":0.028114}],"exchange":"NYSE","name":"美国血液技术","nameEN":"Haemonetics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美国血液技术(HAE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美国血液技术(HAE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美国血液技术,HAE,美国血液技术股票,美国血液技术股票老虎,美国血液技术股票老虎国际,美国血液技术行情,美国血液技术股票行情,美国血液技术股价,美国血液技术股市,美国血液技术股票价格,美国血液技术股票交易,美国血液技术股票购买,美国血液技术股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美国血液技术(HAE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美国血液技术(HAE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}